- Home
- BMY vs FCX Comparison
BMY vs FCX Comparison
Compare BMY & FCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMY | FCX |
|---|---|---|
| Founded | 1887 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.5B | 96.9B |
| IPO Year | 2006 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BMY | FCX |
|---|---|---|
| Price | $67.28 | $77.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 16 |
| Target Price | ★ $61.73 | $60.80 |
| AVG Volume (30 Days) | ★ 11.9M | 11.7M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | ★ 4.38% | 1.05% |
| EPS Growth | ★ 178.46 | N/A |
| EPS | ★ 2.93 | 1.29 |
| Revenue | ★ $48,194,000,000.00 | $25,915,000,000.00 |
| Revenue This Year | N/A | $14.25 |
| Revenue Next Year | N/A | $20.78 |
| P/E Ratio | ★ $22.87 | $59.44 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $42.52 | $35.15 |
| 52 Week High | $68.64 | $77.33 |
Technical Indicators
Market Signals| Indicator | BMY | FCX |
|---|---|---|
| Relative Strength Index (RSI) | 63.48 | 70.24 |
| Support Level | $56.46 | $57.34 |
| Resistance Level | $68.10 | N/A |
| Average True Range (ATR) | 1.51 | 2.35 |
| MACD | 0.04 | 0.89 |
| Stochastic Oscillator | 72.52 | 89.11 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About FCX Freeport-McMoRan Inc.
Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.1 million metric tons of copper (its share) in 2025, making it the one of the world's largest copper miners by volume. It also sold about 530,000 ounces of gold, mostly from Grasberg, and 74 million pounds of molybdenum. It had about 25 years of copper reserves at the end of December 2025. We expect it to sell about 1.3 million metric tons of copper and 610,000 ounces of gold midcycle in 2030.